The DEK Oncogene Is a Target of Steroid Hormone Receptor Signaling in Breast Cancer

Expression of estrogen and progesterone hormone receptors indicates a favorable prognosis due to the successful use of hormonal therapies such as tamoxifen and aromatase inhibitors. Unfortunately, 15–20% of patients will experience breast cancer recurrence despite continued use of tamoxifen. Drug re...

Descripción completa

Detalles Bibliográficos
Autores principales: Privette Vinnedge, Lisa M., Ho, Shuk-Mei, Wikenheiser-Brokamp, Kathryn A., Wells, Susanne I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468546/
https://www.ncbi.nlm.nih.gov/pubmed/23071688
http://dx.doi.org/10.1371/journal.pone.0046985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3468546/
https://www.ncbi.nlm.nih.gov/pubmed/23071688
http://dx.doi.org/10.1371/journal.pone.0046985

Ejemplares similares